M&T BANK CORP - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 874 filers reported holding NOVARTIS A G in Q3 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.

Quarter-by-quarter ownership
M&T BANK CORP ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$19,075,903
-5.7%
187,275
-6.6%
0.08%0.0%
Q2 2023$20,232,649
+8.6%
200,499
-0.9%
0.08%
+5.6%
Q1 2023$18,623,211
-32.9%
202,422
-36.7%
0.07%
+28.6%
Q4 2022$27,751,914
+76.4%
319,925
+54.5%
0.06%
-20.0%
Q3 2022$15,736,000
+11.1%
207,027
+2.2%
0.07%
+4.5%
Q2 2022$14,170,000
-4.8%
202,614
+19.5%
0.07%
+1.5%
Q1 2022$14,883,000
+9.9%
169,616
+9.5%
0.07%
+15.8%
Q4 2021$13,546,000
-20.9%
154,867
-26.1%
0.06%
-26.0%
Q3 2021$17,128,000
-8.4%
209,443
+2.2%
0.08%
-6.1%
Q2 2021$18,698,000
+2.4%
204,941
-4.0%
0.08%
+3.8%
Q1 2021$18,251,000
-16.3%
213,511
-7.5%
0.08%
-17.7%
Q4 2020$21,808,000
+4.9%
230,940
-3.4%
0.10%
-5.9%
Q3 2020$20,798,000
-0.5%
239,158
-0.1%
0.10%
-8.9%
Q2 2020$20,904,000
+7.8%
239,332
+1.8%
0.11%
-2.6%
Q1 2020$19,384,000
-10.8%
235,085
+2.4%
0.12%
+12.7%
Q4 2019$21,732,000
+8.6%
229,501
-0.3%
0.10%
+2.0%
Q3 2019$20,012,000
-6.0%
230,287
-1.2%
0.10%
-9.9%
Q2 2019$21,288,000
-6.7%
233,140
-1.7%
0.11%
-6.7%
Q1 2019$22,813,000
+12.2%
237,288
+0.1%
0.12%
+1.7%
Q4 2018$20,331,000
-1.7%
236,938
-1.3%
0.12%
+13.6%
Q3 2018$20,678,000
+13.3%
239,993
-0.7%
0.10%
+5.1%
Q2 2018$18,250,000
-7.7%
241,596
-1.2%
0.10%
-7.5%
Q1 2018$19,762,000
-8.4%
244,411
-4.8%
0.11%
-6.2%
Q4 2017$21,567,000
-3.9%
256,860
-1.7%
0.11%
-7.4%
Q3 2017$22,431,000
+5.3%
261,270
+2.4%
0.12%
-3.2%
Q2 2017$21,303,000
+11.6%
255,223
-0.7%
0.13%
+9.6%
Q1 2017$19,086,000
+3.7%
256,981
+1.7%
0.12%0.0%
Q4 2016$18,404,000
-9.5%
252,662
-1.9%
0.12%
-11.5%
Q3 2016$20,338,000
-2.9%
257,578
+1.5%
0.13%
-7.8%
Q2 2016$20,947,000
+2.0%
253,868
-10.5%
0.14%
+1.4%
Q1 2016$20,543,000
-20.0%
283,686
-4.9%
0.14%
-18.2%
Q4 2015$25,666,000
-6.4%
298,307
-0.1%
0.17%
-9.1%
Q3 2015$27,417,000
-7.1%
298,561
-0.6%
0.19%
+5.1%
Q2 2015$29,524,000
-1.6%
300,221
-1.3%
0.18%
-4.8%
Q1 2015$29,990,000
+2.8%
304,128
-4.1%
0.19%
+2.2%
Q4 2014$29,180,000
-1.4%
317,098
+0.2%
0.18%
-3.7%
Q3 2014$29,591,000
+922.1%
316,500
+889.6%
0.19%
+57.0%
Q2 2014$2,895,000
+6.7%
31,982
+0.2%
0.12%
+7.1%
Q1 2014$2,713,000
+2.6%
31,904
-3.0%
0.11%
+1.8%
Q4 2013$2,644,000
+3.7%
32,889
-1.0%
0.11%
-9.0%
Q3 2013$2,549,000
+8.1%
33,220
-0.4%
0.12%
+7.0%
Q2 2013$2,359,00033,3530.11%
Other shareholders
NOVARTIS A G shareholders Q3 2016
NameSharesValueWeighting ↓
PRENTISS SMITH & CO INC 127,510$11,721,0006.50%
MANAGED ASSET PORTFOLIOS, LLC 127,716$11,740,0006.04%
EXENCIAL WEALTH ADVISORS, LLC 116,917$10,747,0005.25%
MCDANIEL TERRY & CO 181,095$16,646,0004.64%
Fayerweather Charles 18,180$1,671,0004.54%
Osher Van de Voorde Investment Management 78,138$7,182,0004.38%
BROWN BROTHERS HARRIMAN & CO 9,291,495$854,074,0004.35%
Boulegeris Investments, Inc. 61,322$5,637,0004.31%
DODGE & COX 45,723,035$4,202,861,0004.23%
WHV Investments, Inc. 1,603,476$152,945,0004.23%
View complete list of NOVARTIS A G shareholders